A Study to Evaluate SGB-3403 in Healthy Volunteers and Subjects With Elevated Low-Density Lipoprotein Cholesterol (LDL-C)

Conditions: Hyperlipidemias Interventions: Drug: SGB-3403; Other: Atorvastatin; Other: Placebo Sponsors: Suzhou Sanegene Bio Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials